Search clinical trials for: Modulation of FiO2

Total 10000 results

St. Jude Children's Research Hospital

Completed

Ethanol Lock Therapy for Treatment and Secondary Prophylaxis of Central Line-Associated Bloodstream Infection

Central Line-Associated Bloodstream Infection

United States, Australia
Genentech, Inc.
Hoffmann-La Roche; Chugai Pharmaceutical

Completed

A Study of Bevacizumab in Combination With Capecitabine and Cisplatin as First-line Therapy in Patients With Advanced Gastric Cancer (AVAGAST)

Adenocarcinoma

United States
University of California, Davis
Sanofi

Withdrawn

Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Patients With Colorectal Cancer

Colorectal Cancer | Metastatic Cancer

United States
Genentech, Inc.

Completed

A Study of PRO95780 in Combination With Cetuximab and Irinotecan Chemotherapy or the FOLFIRI Regimen With Bevacizumab in Patients With Previously Treated Metastatic Colorectal Cancer (APM4187g)

Colorectal Cancer
Bionor Immuno AS
Celgene Corporation

Completed

Vacc-4x + Lenalidomide vs. Vacc-4x +Placebo in HIV-1-infected Subjects on Antiretroviral Therapy (ART) (IMID)

HIV-1 Infection

Germany
Spanish Society of Cardiology
Sanofi; Fondo de Investigacion Sanitaria; Boston Scientific Corporation; Medtronic and other collaborators

Terminated

Thrombolysis Versus Primary Angioplasty for AMI in Elderly Patients (TRIANA)

Acute Myocardial Infarction

Spain
Washington University School of Medicine

Completed

Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors

Glioma | Ganglioglioma | Ganglioneuroma | Astrocytoma, Oligoastrocytoma, Mixed | Glioblastoma Multiforme Glioma

United States
Centre Hospitalier Universitaire de Besancon
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Biweekly Versus Triweekly Raltitrexed With Oxaliplatin (With or Without Bevacizumab) in First-line Metastatic Colorectal Cancer (EROS)

Metastatic Colorectal Cancer

France
Amgen

Completed

Phase 1b/2 Trial of AMG386 With Pemetrexed and Carboplatin in Non-Small Cell Lung Cancer

Non Small Cell Lung Cancer

United States, Canada, Australia, Spain, Belgium, Greece
Massachusetts General Hospital
Pfizer; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center

Completed

Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma

Renal Cell Carcinoma | Neoplasm Metastases

United States
University of Arizona

Withdrawn

Combo of Abraxane, TMZ, Bevacizumab in Metastatic Melanoma With Brain Metastases

Metastatic Melanoma | Brain Metastases

United States
Memorial Sloan Kettering Cancer Center
Pfizer

Completed

Gemcitabine, Cisplatin, and Sunitinib (GC-S) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer

Bladder Cancer | Urinary Bladder

United States
Duke University
Sanofi; Pfizer

Terminated

Multimodality Phase II Study in Prostate Cancer

Prostate Cancer

United States
Shanghai Zhongshan Hospital

Unknown

The Effect of Anticoagulation After Endoscopic Therapy in Cirrhotic Patients With Portal Vein Thrombosis

Liver Cirrhosis | Portal Vein Thrombosis

China
Hoffmann-La Roche

Completed

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Glioblastoma Multiforme

Germany
University Hospital of Crete

Terminated

Irinotecan, Capecitabine and Avastin for Metastatic Colorectal Cancer as Salvage Treatment

Metastatic Colorectal Cancer

Greece
Cubist Pharmaceuticals LLC

Completed

Outcomes and Safety Trial Investigating Ecallantide's Effect on Reducing Surgical Blood Loss Volume in Subjects at High Risk of Bleeding Exposed to Cardio-pulmonary Bypass During Cardiac Surgery (CONSERV-2)

Surgical Procedures, Operative | Bloodloss

Germany, Poland, United States
SCRI Development Innovations, LLC
Genentech, Inc.

Completed

Trial of Poor Performance Status Patients (ToPPS) (ToPPS)

Non Small Cell Lung Cancer

United States
Ohio State University Comprehensive Cancer Center
Eli Lilly and Company; Genentech, Inc.

Completed

Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer

United States
Si-Yu Wang

Completed

Neoadjuvant Pemetrexed, Carboplatin and Bevacizumab in Unresectable, Locally Advanced Lung Adenocarcinoma

Lung Cancer

China
University of California, San Francisco

Completed

Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma (AVF4120s)

Glioblastoma | Gliosarcoma

United States
Hoffmann-La Roche

Completed

A Study of Tarceva (Erlotinib) in Combination With Avastin (Bevacizumab) in Patients With Advanced Non-Small Cell Lung Cancer.

Non-Small Cell Lung Cancer

Belgium, Spain, Korea, Republic of, Taiwan, France, Netherlands, Singapore, Italy, Lithuania, Poland, Australia, United Kingdom, Romania
Duke University
National Cancer Institute (NCI)

Completed

Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant Glioma

Brain and Central Nervous System Tumors

United States
University Medical Center Groningen

Unknown

89Zr-bevacizumab PET Scan in Patients With Relapsing Multiple Myeloma

Multiple Myeloma

Netherlands
Centro Cardiologico Monzino
Catholic University, Italy; University of Chieti

Unknown

Antiplatelet Effect of Low Doses of Aspirin Taken Every 12 Hours in Patients Undergoing Coronary Artery Bypass Graft and/or Aortic Valve Surgery (ASABYVALV)

Coronary Arteriosclerosis

Italy
Pfizer

Completed

A Safety Study Of Sunitinib In Combination With Pemetrexed In Patients With Advanced Solid Malignancies

Neoplasm, Malignant

Japan
University of New Mexico

Completed

A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors

Cancer | Brain and Nervous System

United States
Celgene Corporation
Prologue Research International

Terminated

Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid® CC-5013) With Liposomal Doxorubicin In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma

Ovarian Cancer

United States
Ministry of Health, Labour and Welfare, Japan
Bayer; Japan Heart Foundation

Unknown

Japanese Primary Prevention Project With Aspirin

Hypertension | Diabetes Mellitus | Hyperlipidemia

Japan
University Health Network, Toronto

Recruiting

Using Radiotherapy and Immunotherapy to Treat Advanced Liver Cancer Before Transplant (MacroTrans)

Hepatocellular Carcinoma (HCC) | Liver Transplant Surgery | Macrovascular Invasion | Downstaging

Canada
University Hospital, Caen

Recruiting

Short Versus Long Antiplatelet Therapy After TAVI (SOLOTAVI)

Transcatheter Aortic Valve Replacement

France
Navy General Hospital, Beijing

Not yet recruiting

Zanubrutinib and Lenalidomide as Maintenance Therapy in DLBCL

Diffuse Large B-cell Lymphoma

China
Harbin Medical University

Not yet recruiting

Liposomal Irinotecan and Capecitabine Plus Bevacizumab as Second-line Therapy in Metastatic Colorectal Cancer

Colorectal Cancer
Rajavithi Hospital

Recruiting

Comparative Study of Tranexamic Acid, Estrogen for Treatment AUB in DMPA Users

Abnormal Uterine Bleeding | Tranexamic Acid | Estrogen | Depot Medroxyprogesterone Acetate

Thailand
Catharina Ziekenhuis Eindhoven

Recruiting

Intraperitoneal Irinotecan With Concomitant FOLFOX and Bevacizumab (INTERACT-II)

Colorectal Cancer | Peritoneal Metastases

Netherlands
Shuhong Yi

Recruiting

Hepatic Arterial Infusion Chemotherapy in Combination With Atezolizumab and Bevacizumab for Second-line Treatment of Patients With Recurrent Liver Cancer After Liver Transplantation

Recurrent Liver Cancer After Liver Transplantation

China
Guangzhou Gloria Biosciences Co., Ltd.

Not yet recruiting

A Study of GLS-010 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer

Persistent, Recurrent, or Metastatic Cervical Cancer

China
RenJi Hospital

Recruiting

Id and Rd Maintenance Regimens After Induction of Remission in Multiple Myeloma.

Overall Survival | Progression Free Survival | Maintenance

China
ALX Oncology Inc.
Eli Lilly and Company

Active, not recruiting

A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)

Gastric Cancer | Gastric Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma

United States, Spain, France, Korea, Republic of, Australia, United Kingdom, Taiwan, Belgium, Japan, Czechia, Italy, Singapore
Xijing Hospital

Enrolling by invitation

Sulodexide in Controlling the Recurrence of Psoriasis

Psoriasis (PsO) | Randomised Controlled Trial

China
David O'Malley
Genentech, Inc.

Completed

Evaluation of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma

Endometrial Cancer

United States
Shandong New Time Pharmaceutical Co., LTD

Enrolling by invitation

A Phase Ⅱ/Ⅲ Study of Rulonilimab Plus Chemotherapy± Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer

Cervical Cancer

China
Pfizer

Terminated

A BRIDGING STUDY OF PF-06439535 (CN) PLUS PACLITAXEL-CARBOPLATIN VERSUS BEVACIZUMAB PLUS PACLITAXEL-CARBOPLATIN IN NSCLC

Advanced Non-squamous NSCLC

China
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Completed

A Study Evaluating S 95005 Plus Bevacizumab and Capecitabine Plus Bevacizumab in Patients With Previously Untreated Colorectal Cancer Who Are Non-eligible for Intensive Therapy (TASCO1)

Metastatic Colorectal Cancer

United Kingdom, Spain, Germany, Poland, Australia, Belgium, Brazil, Denmark, France, Italy, Netherlands, Russian Federation
Columbia University

Terminated

A Study of Cisplatin + Pemetrexed + Avastin as First-Line Therapy

Non-Small Cell Lung Cancer

United States
National Institutes of Health Clinical Center (CC)

Completed

Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate Cancer

Recurrent Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer

United States
Medical University of Lublin

Completed

Comparison of Efficacy and Safety of Mitomycin and Aflibercept Used to Support Primary Trabeculectomy.

Eye Diseases | Glaucoma Surgery | Optic Nerve Damage

Poland
Cairo University

Completed

Blood Loss During Cesarean Delivery in Placenta Previa Patients

Placenta Previa

Egypt
M.D. Anderson Cancer Center
Genentech, Inc.; OSI Pharmaceuticals

Completed

Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line Therapy

Liver Cancer

United States
Capital Institute of Pediatrics, China

Completed

Observation and Treatment of Pulmonary Microthrombosis in Childhood Pneumonia With Elevated D-dimer

Pneumonia

China

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations